top
Search terms
Results 61 - 70 of 103 - ordered by :
Pages: 1 ... 4 5 6 7 8 9 10 ... 11
Ehjcvp

A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease Methods and ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, D.G. Kallend, J.A.A. Reijers, S.E. Bellibas, A. Bobillier, H. Kempen, J. Burggraaf, M. Moerland, P.L.J. Wijngaard

Date : 01/01/2016
Ehjcvp

Abstract Aortic valve stenosis (AVS) is associated with significant morbidity and mortality, especially in the presence of symptoms and echocardiographic signs of left ventricular remodelling (i.e. ...

European Heart Journal - Cardiovascular Pharmacotherapy, Review, Charlotte Andersson, Jawdat Abdulla

Date : 11/09/2016
Ehjcvp

Abstract Aims Therapeutic windows for residual platelet reactivity in patients with coronary artery disease on P2Y12 inhibitors were proposed in a consensus document. Conclusions Our results suggest ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Minka J.A. Vries, Heleen J. Bouman, Renske H. Olie, Leo F. Veenstra, Suzanne Zwaveling, Paul W.M. Verhezen, Arina J. ten ...

Date : 07/09/2016
Ehjcvp

Abstract Aims To determine whether risk factor changes over 6 years were associated with the incidence of atrial fibrillation (AF) among middle-aged men in the Malmö Preventive Project (MPP) ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Linda S.B. Johnson, Tord Juhlin, Gunnar Engström, Peter M. Nilsson

Date : 01/04/2016
Ehjcvp

Significant evidence demonstrated that atherosclerotic plaques are not passive collections of lipids, but sites of active interactions between cells of the immune system and vascular cells that ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Jessica Bullenkamp, Sip Dinkla, Juan Carlos Kaski, Ingrid E. Dumitriu

Date : 01/07/2016
Ehjcvp

Exploring the potential of low-dose sulfasalazine in stable coronary artery disease patients: randomized, double-blind, placebo-controlled study Recent statistics reports by Centre for Disease ...

European Heart Journal - Cardiovascular Pharmacotherapy, CORRESPONDENCE, Kanchan Vohra, Pawan Krishan, Sudhir Varma, Harpreet Singh Kalra

Date : 01/10/2015
Ehjcvp

Differences between sexes and during pubertal development suggest an influence of sex hormones on plasma PCSK9 concentrations There were no sex differences in PCSK9 concentrations in young adults, ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Eliano P. Navarese, Michalina Kołodziejczak, Dimitrios Dimitroulis, Georg Wolff, Hans L. Busch, Fiorella Devito, Alessandro ...

Date : 01/01/2016
Ehjcvp

Glycoprotein IIb/IIIa receptor inhibitors (GPIs) block the final common pathway leading to platelet aggregation that occurs via the cross-linking of fibrinogen and von Willebrand factor upon exposure ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Jeffrey D. Wessler, Robert P. Giugliano

Date : 01/04/2015
Ehjcvp

While the absolute number of comorbidities such as renal disease, liver disease, chronic obstructive pulmonary disease, and vascular disease has increased, there was a relative decrease of ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Lorenz Koller, Alexander Niessner

Date : 01/07/2015
Ehjcvp

Effects of reninangiotensinaldosterone system blockade on cardiovascular system The benefits of blocking the RAAS in heart failure (HF) and post-myocardial infarction (MI) were largely proved many ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Gema Ruiz-Hurtado, Luis Miguel Ruilope

Date : 01/04/2015